Clinical Trial

XVIVO Presents Interim Report January-June 2023

GOTHENBURG, SWEDEN / ACCESSWIRE / July 13, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) "Continued momentum for our business"Second quarter 2023…

12 months ago

XVIVO has decided to close the PrimECC(R) Study for Further Patient Inclusions – Strategic Opportunities will be Evaluated

GOTHENBURG, SE / ACCESSWIRE / July 12, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) PrimECC is a solution used to prime…

12 months ago

Florence Healthcare Appoints Jason Reynolds as Chief Revenue Officer

ATLANTA, GA / ACCESSWIRE / July 12, 2023 / Florence Healthcare™, a leading global provider of clinical trial site enablement…

12 months ago

AngioDynamics Reports Fiscal Year 2023 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2024 Guidance

Fiscal Year 2023 Fourth Quarter Highlights Net sales of $91.1 million increased 4.7% compared to the prior-year quarter Med Tech…

12 months ago

Announcing Olink® Explore HT – A New Era in Proteomics

A High-throughput Protein Biomarker Discovery Platform with Proven Specificity at Any Scale Olink Explore HT Olink® Explore HT is a…

12 months ago

T2 Biosystems Announces Preliminary Second Quarter 2023 Financial Results

Received record quarterly sepsis test panel orders and strengthened balance sheetLEXINGTON, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems,…

12 months ago

LianBio Announces Clinical Supply Agreement with AstraZeneca in China to Evaluate BBP-398 in Combination with Osimertinib in Patients with Non-Small Cell Lung Cancer with EGFR Mutations

SHANGHAI, China and PRINCETON, N.J., July 12, 2023 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing…

12 months ago

Aridis’ AR-301 Monoclonal Antibody is Among the First Biologics to Receive FDA’s Qualified Infectious Diseases Product (QIDP) Designation

QIDP designation for Biologics provides FDA Priority Review statusLOS GATOS, Calif., July 12, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc.…

12 months ago

Lumos Pharma to Participate in the Oppenheimer 2023 Montauk Life Sciences Summit

AUSTIN, Texas, July 12, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for…

12 months ago

Ocular Therapeutix™ Announces Appointment of New Board Member

Dr. Adrienne Graves to join Board of DirectorsBEDFORD, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL), a…

12 months ago